Additionally, the fragment peptides of HBA1, HBB, GLUL, ACTB, and CFL1 in Figure 9, exclusively marking GBM saliva and also identified in GBM tumor cells [65] and GBM CUSA fluid [20], could represent a potential panel of GBM biomarkers to further investigate. This evidence concerns the gene CFL1 and glioblastoma.